Gynecology Devices Market Size, Share | Industry Growth 2028

The gynecology devices market is projected to reach US$ 25,131.22 million by 2028 from US$ 13,658.41 million in 2022; it is expected to grow at a CAGR of 10.7% from 2022 to 2028.

Factors such as the surging number of gynecological diseases and the rising number of advanced medical devices for women drive the gynecology devices market growth. However, stringent regulatory policies hinder the market growth.

Gynecology deals with the problems related to the reproductive systems. The growing female population and women's lifestyle choices contribute to an increase in gynecological diseases. Gynecological devices are surgical and monitoring devices used to treat and diagnose gynecological disorders and conditions in hospitals, clinics/ASC, research institutes, and diagnostic labs. The devices are used in gynecological procedures, such as uterine fibroid remobilization, assisted reproduction, hysteroscopy, colposcopes, and female sterilization. Gynecological devices are available in coated and uncoated stainless steel and are designed to provide greater productivity to physicians while providing maximum benefit to the patients.

Strategic Insights

North America is likely to dominate the gynecology devices market during the forecast period. The US held the largest share of the North American market in 2022. The country is expected to dominate the regional market during the forecast period, owing to the availability of well-established healthcare infrastructure, high rate of awareness regarding the availability of diagnostic tests and treatments, and rising reimbursement coverage. According to the American Cancer Society, in 2019, an estimated 1,762,450 new cancer cases were diagnosed in the US. In American women, there are the growing cases of cervical cancer. This rising number of cancer cases is augmenting the demand for gynecology devices across the country.

The gynecology devices market is segmented on the basis of product, end user, and geography. By geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The gynecology devices market report offers insights and in-depth analysis of the market, emphasizing parameters such as market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.       

Lucrative Regions for Gynecology Devices Market

Get more information on this report : Request Free Sample PDF

Market Insights
Rise in Incidence of Gynecological Diseases

Gynecological diseases comprise various diseases, including uterine cancer, cervical cancer, polycystic ovary syndrome, and ovarian cancer. As per the Institute for Health Metrics and Evaluation (IHME) research data, in 2019, ~8,640 deaths were caused due to gynecological diseases, and 37% of the female population was living with these diseases globally. For instance, endometrium cancer is the most common cancer of the female reproductive organs in the US, and uterine cancer is the sixth most common cancer in women in the country. According to the American Society of Clinical Oncology (ASCO) data, ~417,367 people were diagnosed with uterine cancer in 2020. Women diagnosed with endometrial cancer are typically aged between 60 years and above. As per the American Cancer Society, ~65,950 new cases of uterine cancer will be diagnosed by 2022, with ~12,550 associated deaths among women patients in the US. Moreover, according to global cancer observatory data, cervical cancer is the 7th most common cancer globally, with more than ~604,000 new cases diagnosed in 2020. Cervical cancer is a type of cancer that can be prevented and treated. The early detection of cervical cancer can be prevented with human papillomavirus (HPV) vaccination and managed effectively. Therefore, the rise in the number of gynecological disorders and the easy prevention and treatment are encouraging women to get diagnosed and treated. Further, the availability of gynecological devices used for the treatment of gynecological conditions and disorders is driving the growth of the gynecology devices market. 

Product Insights

Based on product, the global gynecology devices market is segmented into surgical device, hand instruments, and diagnostic imaging systems. In 2022, the surgical device segment held the largest market share. Moreover, the same segment is expected to register the highest CAGR in the market during the forecast period. The surgical devices used for gynecology procedures are specially designed. Since the uterus is a tough muscle, the instruments used for gynecological purposes are generally heavier than the instruments used for general surgeries. A few of the commonly used surgical devices for gynecological purpose are vaginal speculums, tenaculums, scissors, biopsy punches, Heaney needle holders, and Heaney or Ballentine forceps. Manufacturers operating in the gynecology devices market are focusing on increasing their current product offerings and expanding their manufacturing base. Moreover, the market for the surgical devices segment is further segmented into gynecological endoscopy devices, endometrial ablation devices, female sterilization & contraceptive devices, and fluid management. The gynecological endoscopy devices segment is expected to register the highest CAGR in the market during the forecast period. Gynecological endoscopy devices are specially designed to diagnose most frequent female disorders and pathologies, such as small vaginal hemorrhages, infertility problems, or endometrial polyps. Devices generally used for endoscopy are hysteroscopy and laparoscopy. It ensures quick recovery of a patient, and one can return to their routine activities at the earliest. Thus, owing to these factors, the global gynecology devices market for the surgical devices segment is expected to grow at a steady pace during the forecast period.

Gynecology Devices Market, by Product – 2022 and 2028

Get more information on this report : Request Free Sample PDF

End User Insights

Based on end user, the global gynecology devices market is segmented into hospitals, diagnostic centers, clinics, and others. In 2022, the hospitals segment held the largest share of the market. Moreover, the same segment is expected to register the highest CAGR in the market during forecast period. Hospitals are the largest entities that have all the facilities. Due to the development in the healthcare facilities, hospitals are upgraded with the modernized equipment and are installed with the digital pathology and artificial intelligence. These technologies assist in communicating among the inter departments and allow to share data across the domain. Hospitals are associated with various doctors, specialist doctors, and other professionals who provide better healthcare services. All gynecological diseases can be treated in the hospitals, and better nursing services are being provided by the staffs. Rising awareness regarding birth control devices, surgeries, and growth in hysterectomy and laparoscopy procedures are estimated to escalate the market growth for the segment. Besides this, growing number of female sterilization procedures is playing a vital role in the development of the segment. Therefore, owing to all the above-mentioned factors, the global gynecology devices market for the hospital segment is likely to grow in the coming years.

Product launches and collaborations are highly adopted strategies by the global gynecology devices market players to expand their global footprints and product portfolios. The players also focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. They aim to flourish their market shares with the development of innovative products. A few of the recent key market developments are listed below: 

• In April 2022, GE Healthcare and Medtronic collaborated with a focus on the unique needs and demand for care at ambulatory surgery centers (ASCs) and office-based labs (OBLs). Under the new collaboration, customers can access extensive product portfolios, financial solutions, and exceptional service.
• In January 2021, Cooper Surgical acquired Embryo Options, an established leader in cryo-storage software solutions for clinics and patients. The acquisition complements Cooper Surgical’s comprehensive portfolio of innovative fertility offerings. Patients using the Embryo Options platform have access to online resources to learn more about continuing to store specimens, for subsequent ART treatment cycles and thawing and discarding, or donating specimens to other patients or for research.

Company profile

• CooperSurgical, Inc
• Boston Scientific Corporation
• Hologic, Inc.
• Medtronic
• Stryker
• KARL STORZ SE & Co. KG
• Olympus Corporation
• General Electric Company
• Richard Wolf GmbH.
• Ethicon.